BLyS Levels in Systemic Lupus Erythematosus
Author Information
Author(s): Christopher E. Collins, Amanda L. Gavin, Thi-Sau Migone, David M. Hilbert, David Nemazee, William Stohl
Primary Institution: University of Southern California
Hypothesis
Increased levels of BLyS mRNA may correlate better with disease activity in systemic lupus erythematosus than plasma BLyS protein levels.
Conclusion
BLyS mRNA levels are more closely associated with disease activity in SLE patients than BLyS protein levels.
Supporting Evidence
- BLyS mRNA levels were significantly higher in SLE patients compared to RA patients and healthy controls.
- Changes in SLE Disease Activity Index scores correlated more closely with changes in BLyS mRNA levels than with changes in BLyS protein levels.
- Full-length BLyS and ΔBLyS mRNA levels were both elevated in SLE patients.
Takeaway
This study found that measuring a specific type of BLyS in the blood can help doctors understand how active a patient's lupus is, better than measuring another form of BLyS.
Methodology
The study measured BLyS mRNA and protein levels in blood samples from SLE patients and correlated these levels with disease activity scores.
Potential Biases
Potential bias due to the presence of autoantibodies affecting BLyS protein measurements.
Limitations
The study's sample size was limited to specific patient groups, which may not represent the broader SLE population.
Participant Demographics
60 SLE patients, 60 RA patients, and 30 healthy controls; predominantly Hispanic population.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website